• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    TG Therapeutics, Inc. - Common Stock (NQ:TGTX)

    34.87 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 16, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,073
    Open 34.87
    Bid (Size) 34.20 (8)
    Ask (Size) 34.94 (2)
    Prev. Close 34.87
    Today's Range 34.87 - 34.87
    52wk Range 22.61 - 46.48
    Shares Outstanding 154,420,772
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Small-Cap Biotech Climb Bio's Lead Drug Candidate Has Larger Long-Term Opportunity
    William Blair assigns Climb Bio an Outperform rating, projecting peak sales of $1.9 billion and long-term growth for its therapy pipeline. 
    Via Benzinga
    TG THERAPEUTICS INC (NASDAQ:TGTX) Shows High Growth Momentum and Technical Breakout Setup
    TG Therapeutics (TGTX) shows explosive EPS growth up to 1,300% and strong sales momentum. With a perfect 10 technical rating and a bullish chart setup, it's a high-growth stock to watch. 
    Via Chartmill

    Performance

    YTD
    +12.3%
    +12.3%
    1 Month
    +9.0%
    +9.0%
    3 Month
    -11.0%
    -11.0%
    6 Month
    -9.0%
    -9.0%
    1 Year
    +42.3%
    +42.3%

    More News

    Read More
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    TG Therapeutics CEO Voices Strong Conviction In Briumvi With New $100 Million Buyback
    Via Benzinga
    TG Therapeutics Board Authorizes New $100M Share Repurchase Program
    Via Stocktwits
    Earnings Scheduled For August 4, 2025
    Via Benzinga
    What's Next: TG Therapeutics's Earnings Preview
    Via Benzinga
    Earnings Scheduled For May 5, 2025
    Via Benzinga
    TG Therapeutics Stock Tumbles 15% After Disappointing Q2, But Company Reaffirms Confidence In Multiple Sclerosis Drug
    Via Stocktwits
    Topics Earnings
    Crude Oil Falls 1.5%; ON Semiconductor Shares Plunge After Q2 Results
    Via Benzinga
    Briumvi's Strong Sales Can't Stop TG Therapeutics Stock Slide
    Via Benzinga
    TG Therapeutics Q2 Revenue Up 91%
    Via The Motley Fool
    Topics Intellectual Property
    Why Top 3% Stock TG Therapeutics Crashed Despite Raising Its 2025 Outlook
    Via Investor's Business Daily
    Traders are paying attention to the gapping stocks in Monday's session.
    Via Chartmill
    TG Therapeutics Inc (NASDAQ:TGTX) Reports Mixed Q2 2025 Results, Raises Full-Year BRIUMVI Revenue Guidance
    Via Chartmill
    TG THERAPEUTICS INC (NASDAQ:TGTX) – A High Growth Momentum Stock with Strong Technical Setup
    Via Chartmill
    TG THERAPEUTICS INC (NASDAQ:TGTX) - A High-Growth Stock Meeting Minervini's Trend Template
    Via Chartmill
    Cramer Backs This Mining Giant After $1.6B Bet
    Via Benzinga
    TG THERAPEUTICS INC (NASDAQ:TGTX) - A High Growth Momentum Stock with Strong Technical Setup
    Via Chartmill
    TG Therapeutics Boosts Retail Sentiment With Q1 Revenue Beat Even As Stock Tumbles On Profit Miss, Conservative Outlook
    Via Stocktwits
    TG Therapeutics Falls Short On Earnings, But Briumvi Sales Steal the Show
    Via Benzinga
    Why TG Therapeutics Stock Was Tumbling Today
    Via The Motley Fool
    Crude Oil Falls Over 2%; ISM Services PMI Rises In April
    Via Benzinga
    TG Therapeutics Stock Tumbles After Q1 Earnings Fall Short Of Wall Street Estimates: But Retail’s Optimistic
    Via Stocktwits
    Applying Mark Minervini’s growth stock checklist to TG THERAPEUTICS INC (NASDAQ:TGTX)
    Via Chartmill

    Frequently Asked Questions

    Is TG Therapeutics, Inc. - Common Stock publicly traded?
    Yes, TG Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does TG Therapeutics, Inc. - Common Stock trade on?
    TG Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for TG Therapeutics, Inc. - Common Stock?
    The ticker symbol for TG Therapeutics, Inc. - Common Stock is TGTX on the Nasdaq Stock Market
    What is the current price of TG Therapeutics, Inc. - Common Stock?
    The current price of TG Therapeutics, Inc. - Common Stock is 34.87
    When was TG Therapeutics, Inc. - Common Stock last traded?
    The last trade of TG Therapeutics, Inc. - Common Stock was at 10/16/25 04:00 PM ET
    What is the market capitalization of TG Therapeutics, Inc. - Common Stock?
    The market capitalization of TG Therapeutics, Inc. - Common Stock is 5.38B
    How many shares of TG Therapeutics, Inc. - Common Stock are outstanding?
    TG Therapeutics, Inc. - Common Stock has 5B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.